177 related articles for article (PubMed ID: 23437414)
21. Leishmania donovani activates uncoupling protein 2 transcription to suppress mitochondrial oxidative burst through differential modulation of SREBP2, Sp1 and USF1 transcription factors.
Ball WB; Mukherjee M; Srivastav S; Das PK
Int J Biochem Cell Biol; 2014 Mar; 48():66-76. PubMed ID: 24417972
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
23.
Gupta AK; Ghosh K; Palit S; Barua J; Das PK; Ukil A
FASEB J; 2017 Nov; 31(11):5087-5101. PubMed ID: 28765172
[TBL] [Abstract][Full Text] [Related]
24. Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation.
Lu M; Sun XL; Qiao C; Liu Y; Ding JH; Hu G
Neurobiol Aging; 2014 Feb; 35(2):421-30. PubMed ID: 24041971
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
26. Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum.
Rolland L; Belkaid M; Seye A; Schneider P; Gentilini M
Parasite; 1995 Mar; 2(1):13-21. PubMed ID: 9137640
[TBL] [Abstract][Full Text] [Related]
27. Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin.
Lee SC; Robson-Doucette CA; Wheeler MB
J Endocrinol; 2009 Oct; 203(1):33-43. PubMed ID: 19635759
[TBL] [Abstract][Full Text] [Related]
28. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.
Gonzalez-Lombana C; Gimblet C; Bacellar O; Oliveira WW; Passos S; Carvalho LP; Goldschmidt M; Carvalho EM; Scott P
PLoS Pathog; 2013 Mar; 9(3):e1003243. PubMed ID: 23555256
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.
Quirino GFS; Nascimento MSL; Davoli-Ferreira M; Sacramento LA; Lima MHF; Almeida RP; Carregaro V; Silva JS
Infect Immun; 2016 Aug; 84(8):2289-2298. PubMed ID: 27245409
[TBL] [Abstract][Full Text] [Related]
30. Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.
Domínguez-Bernal G; Horcajo P; Orden JA; De La Fuente R; Herrero-Gil A; Ordóñez-Gutiérrez L; Carrión J
Vet Res; 2012 Aug; 43(1):59. PubMed ID: 22876751
[TBL] [Abstract][Full Text] [Related]
31. Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension.
Dromparis P; Paulin R; Sutendra G; Qi AC; Bonnet S; Michelakis ED
Circ Res; 2013 Jul; 113(2):126-36. PubMed ID: 23652801
[TBL] [Abstract][Full Text] [Related]
32. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
33. Canine leishmaniosis caused by Leishmania major and Leishmania tropica: comparative findings and serology.
Baneth G; Yasur-Landau D; Gilad M; Nachum-Biala Y
Parasit Vectors; 2017 Mar; 10(1):113. PubMed ID: 28285601
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.
Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS
J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous involvement in canine leishmaniosis due to Leishmania infantum (syn. L. chagasi).
Saridomichelakis MN; Koutinas AF
Vet Dermatol; 2014 Apr; 25(2):61-71, e22. PubMed ID: 24461051
[TBL] [Abstract][Full Text] [Related]
36. A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies.
Aslan H; Dey R; Meneses C; Castrovinci P; Jeronimo SM; Oliva G; Fischer L; Duncan RC; Nakhasi HL; Valenzuela JG; Kamhawi S
J Infect Dis; 2013 Apr; 207(8):1328-38. PubMed ID: 23288926
[TBL] [Abstract][Full Text] [Related]
37. Diet-induced obesity promotes systemic inflammation and increased susceptibility to murine visceral leishmaniasis.
Sarnáglia GD; Covre LP; Pereira FE; DE Matos Guedes HL; Faria AM; Dietze R; Rodrigues RR; Maioli TU; Gomes DC
Parasitology; 2016 Oct; 143(12):1647-55. PubMed ID: 27440305
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
Papadogiannakis EI; Koutinas AF
Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
[TBL] [Abstract][Full Text] [Related]
39. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
Satoskar A; Bluethmann H; Alexander J
Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
